Build, discover and catalyse
Approaching the 12th consecutive year, BioTrinity 2018 takes as its theme ‘Next Generation Healthcare‘, explored via a range of insightful keynote and panel discussions including ‘AI and Drug Discovery‘, ‘An insight into Nanotechnology‘, ‘Next Generation Chemistry‘ and ‘Fintech and the Future of the Investment Industry‘ – here is the conference programme.
BioTrinity offers unique access to investors, big pharma executives and innovative CEO’s of emerging R&D companies seeking to strike deals and grow their networks.
We look forward to seeing you there.
BioTrinity is developed and organised by OBN, the not-for-profit Membership organisation supporting and bringing together the life sciences industry, their corporate partners and investors. For more information on OBN visit their website.